1. Banovic, M, Brkovic, V, Nedeljkovic, I, et al. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries. Diab Vasc Dis Res 2016; 13(3): 220–227.
Google Scholar | SAGE Journals | ISI2. Tisminetzky, M, Joffe, S, McManus, DD, et al. Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction. Diab Vasc Dis Res 2014; 11(3): 182–189.
Google Scholar | SAGE Journals | ISI3. Ng, ACT, Delgado, V, Borlaug, BA, et al. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol 2021; 18(4): 291–304.
Google Scholar | Crossref | Medline4. Shah, AD, Langenberg, C, Rapsomaniki, E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol 2015; 3(2): 105–113.
Google Scholar | Crossref | Medline | ISI5. Ponikowski, P, Voors, AA, Anker, SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37(27): 2129–2200.
Google Scholar | Crossref | Medline | ISI6. Banovic, M, Athithan, L, McCann, GP. Aortic stenosis and diabetes mellitus: an ominous combination. Diab Vasc Dis Res 2019; 16(4): 310–323.
Google Scholar | SAGE Journals | ISI7. Song, X, Saito, N, Morimoto, T, et al. Long-term impact of diabetes mellitus on initially conservatively managed patients with severe aortic stenosis. Circ J 2021; 85(7): 1083–1092.
Google Scholar | Crossref | Medline8. Freeman, RV, Otto, CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111(24): 3316–3326.
Google Scholar | Crossref | Medline | ISI9. Rajamannan, NM, Bonow, RO, Rahimtoola, SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007; 4(5): 254–262.
Google Scholar | Crossref | Medline10. Kopytek, M, Zabczyk, M, Mazur, P, et al. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol 2020; 19(1): 92.
Google Scholar | Crossref | Medline11. Galante, A, Pietroiusti, A, Vellini, M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001; 38(4): 1078–1082.
Google Scholar | Crossref | Medline12. Larsson, SC, Wallin, A, Hakansson, N, et al. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol 2018; 262: 66–70.
Google Scholar | Crossref | Medline13. Yan, AT, Koh, M, Chan, KK, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J Am Coll Cardiol 2017; 69(12): 1523–1532.
Google Scholar | Crossref | Medline14. Rathmann, W, Bongaerts, B, Carius, HJ, et al. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther 2018; 56(10): 459–466.
Google Scholar | Crossref | Medline15. van den Boom, L, Kaiser, M, Kostev, K. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices. Diabet Med 2020; 37(8): 1333–1339.
Google Scholar | Crossref | Medline16. Jacob, L, Kaiser, M, Kostev, K. Incidence of antiepileptic drug therapy and factors associated with their prescribing in outpatients with diabetic polyneuropathy. Prim Care Diabetes. 2021; 15(3): 535–540.
Google Scholar | Crossref | Medline17. Kostev, K. Longitudinal changes in HbA1c following therapy intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes in Germany. Diabetes Obes Metab. 2019; 21(7): 1757.
Google Scholar | Crossref | Medline18. Swart, E, Gothe, H, Geyer, S, et al. Good practice of secondary data analysis (GPS): guidelines and recommendations. Gesundheitswesen 2015; 77(2): 120–126.
Google Scholar | Medline19. Harding, JL, Pavkov, ME, Magliano, DJ, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62(1): 3–16.
Google Scholar | Crossref | Medline20. Iwai, K, Ushigome, E, Matsumoto, S, et al. Home blood pressure is associated with cognitive impairment among elderly patients with type 2 diabetes: KAMOGAWA-HBP study. Diab Vasc Dis Res 2019; 16(6): 506–512.
Google Scholar | SAGE Journals | ISI21. Lindman, BR, Clavel, MA, Mathieu, P, et al. Calcific aortic stenosis. Nat Rev Dis Primers 2016; 2: 16006.
Google Scholar | Crossref | Medline22. Hill, AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300.
Google Scholar | SAGE Journals23. Hanefeld, M, Frier, BM, Pistrosch, F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016; 39(Suppl. 2): S205–S209.
Google Scholar | Crossref | Medline24. O’Brien, KD, Reichenbach, DD, Marcovina, SM, et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16(4): 523–532.
Google Scholar | Crossref | Medline25. Otto, CM, Kuusisto, J, Reichenbach, DD, et al. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90(2): 844–853.
Google Scholar | Crossref | Medline | ISI26. Cote, N, Mahmut, A, Bosse, Y, et al. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 2013; 36(3): 573–581.
Google Scholar | Crossref | Medline27. Miller, JD, Weiss, RM, Heistad, DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res 2011; 108(11): 1392–1412.
Google Scholar | Crossref | Medline | ISI28. Calle, MC, Fernandez, ML. Inflammation and type 2 diabetes. Diabetes Metab 2012; 38(3): 183–191.
Google Scholar | Crossref | Medline29. Natorska, J, Wypasek, E, Grudzien, G, et al. Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation 2012; 35(3): 834–840.
Google Scholar | Crossref | Medline30. Tucureanu, MM, Filippi, A, Alexandru, N, et al. Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis. Diab Vasc Dis Res 2019; 16(6): 562–576.
Google Scholar | SAGE Journals | ISI31. Labenz, C, Huber, Y, Michel, M, et al. Nonalcoholic fatty liver disease increases the risk of anxiety and depression. Hepatol Commun 2020; 4(9): 1293–1301.
Google Scholar | Crossref | Medline32. Cheung, D, Heaney, A. Dopamine agonists and valvular heart disease. Curr Opin Endocrinol Diabetes Obes 2009; 16(4): 316–320.
Google Scholar | Crossref | Medline33. Becher, H, Kostev, K, Schroder-Bernhardi, D. Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 2009; 47(10): 617–626.
Google Scholar | Crossref | Medline | ISI